Skip to content
PubMed This is a summary of 35 peer-reviewed journal articles Updated
Medical Genetics

Hyperornithinemia-hyperammonemia-homocitrullinuria (HHH) syndrome: A Patient Guide

At a Glance

HHH syndrome is a rare inherited urea cycle disorder that can raise ammonia and cause dangerous metabolic crises. Long-term stability depends on a specialist-directed low-protein, high-calorie diet, prescribed medicines or amino acids, monitoring, and urgent care when warning symptoms appear.

Hyperornithinemia-hyperammonemia-homocitrullinuria (HHH) syndrome is an exceptionally rare genetic condition that affects the way the body processes protein. It belongs to a group of disorders known as urea cycle disorders, which are characterized by the body’s inability to remove ammonia—a toxic waste product—from the bloodstream. In HHH syndrome, a specific “shuttle” protein called ORNT1 (produced by the SLC25A15 gene) is faulty, creating a metabolic transport impairment that prevents the urea cycle from functioning correctly [1][2].

Because this metabolic “shuttle” is impaired, key ingredients for waste removal cannot reach the parts of the cell where they are needed. This leads to the buildup of three specific substances: ornithine and ammonia in the blood, and homocitrulline in the urine [3][4]. While these markers are the hallmark of the disease, they are not always present in the same amounts, which can sometimes make the initial diagnosis difficult to pinpoint without genetic testing [5].

EMERGENCY ACTION BOX:
If you notice sudden vomiting, unusual sleepiness, confusion, or altered behavior:

  1. Go to the nearest emergency room or call emergency services immediately.
  2. Bring your written emergency letter.
  3. State that the patient has HHH syndrome and needs urgent ammonia testing.
  4. Do not wait for a routine appointment or for symptoms to become severe.

Living with HHH syndrome requires a constant awareness of the body’s metabolic balance. Certain triggers—such as common infections, prolonged fasting, or eating too much protein—can cause ammonia levels to rise suddenly, leading to a metabolic crisis [6]. These episodes are medical emergencies that can cause vomiting, extreme lethargy, and confusion, requiring immediate hospital intervention to protect the brain from injury [7].

The foundation of long-term health is a proactive management plan centered on a specialized diet and medication. Patients work closely with a metabolic team to maintain a carefully monitored low-protein, high-calorie diet that provides enough energy to prevent the body from breaking down its own muscle [8][9]. This is often supplemented with specific amino acids like citrulline or arginine to support the urea cycle (these are strictly specialist-directed based on individual lab patterns, not interchangeable choices), along with “scavenger” medications that provide an alternative route for the body to eliminate ammonia [10][3]. You should never start, stop, or substitute these products without your metabolic team’s guidance.

While HHH syndrome is a lifelong journey that requires careful monitoring of the nervous system and liver, consistent treatment can significantly improve stability and quality of life. By balancing nutrition and staying vigilant against triggers, patients and families can effectively manage the condition and focus on long-term growth and development [11][12].

Common questions in this guide

What is HHH syndrome and what causes it?
HHH syndrome is a rare inherited urea cycle disorder. A faulty SLC25A15 gene affects the ORNT1 transport protein, so the body cannot process protein waste normally and ammonia can build up.
Which HHH syndrome symptoms require emergency care?
Sudden vomiting, unusual sleepiness, extreme lethargy, confusion, or changes in behavior may signal a metabolic crisis. Go to an emergency room or call emergency services immediately, bring the written emergency letter, and state that the patient has HHH syndrome and needs urgent ammonia testing.
What can trigger an ammonia crisis in HHH syndrome?
Common infections, prolonged fasting, and eating too much protein can cause ammonia levels to rise. Follow the sick-day plan provided by the metabolic team and seek urgent guidance if illness affects eating or drinking or if warning symptoms develop.
How is HHH syndrome treated long term?
Treatment is individualized by a metabolic team and may include a low-protein, high-calorie diet, prescribed citrulline or arginine, and ammonia-scavenger medicines. The extra calories help prevent the body from breaking down muscle, and these products should not be started, stopped, or substituted without specialist guidance.
Which tests help diagnose or monitor HHH syndrome?
Evaluation may include blood tests for ammonia and ornithine, urine testing for homocitrulline, and genetic testing for SLC25A15. Because these markers can vary, genetic testing may be needed when initial results are unclear, while ongoing blood testing helps the care team adjust treatment.
Can HHH syndrome affect family members or future family planning?
Because HHH syndrome is linked to a change in SLC25A15, family members and future pregnancies may have genetic implications. Ask the metabolic or genetics team how the specific change affects relatives and family planning.

Get notified when new evidence is published on Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (12)
  1. 1

    Clinical heterogeneity of hyperornithinemia-hyperammonemia-homocitrullinuria syndrome in thirteen palestinian patients and report of a novel variant in the SLC25A15 gene.

    Dweikat I, Khalaf-Nazzal R

    Frontiers in genetics 2022; (13()):1004598 doi:10.3389/fgene.2022.1004598.

    PMID: 36506307
  2. 2

    Pathogenic potential of SLC25A15 mutations assessed by transport assays and complementation of Saccharomyces cerevisiae ORT1 null mutant.

    Marobbio CM, Punzi G, Pierri CL, et al.

    Molecular genetics and metabolism 2015; (115(1)):27-32.

    PMID: 25818551
  3. 3

    The hyperornithinemia-hyperammonemia-homocitrullinuria syndrome.

    Martinelli D, Diodato D, Ponzi E, et al.

    Orphanet journal of rare diseases 2015; (10()):29 doi:10.1186/s13023-015-0242-9.

    PMID: 25874378
  4. 4

    Hyperornithinemia-Hyperammonemia-Homocitrullinuria Syndrome in Vietnamese Patients.

    Nguyen KN, Tran VK, Nguyen NL, et al.

    Medicina (Kaunas, Lithuania) 2024; (60(11)) doi:10.3390/medicina60111877.

    PMID: 39597062
  5. 5

    Hyperornithinemia, Hyperammonemia, and Homocitrullinuria Syndrome Causing Severe Neonatal Hyperammonemia.

    Wild KT, Ganetzky RD, Yudkoff M, Ierardi-Curto L

    JIMD reports 2019; (44()):103-107 doi:10.1007/8904_2018_132.

    PMID: 30187369
  6. 6

    Immune Alterations in a Patient With Hyperornithinemia-Hyperammonemia-Homocitrullinuria Syndrome: A Case Report.

    Silvera-Ruiz SM, Gemperle C, Peano N, et al.

    Frontiers in immunology 2022; (13()):861516 doi:10.3389/fimmu.2022.861516.

    PMID: 35711415
  7. 7

    Late onset hyperornithinemia-hyperammonemia-homocitrullinuria syndrome - how web searching by the family solved unexplained unconsciousness: a case report.

    Silfverberg T, Sahlander F, Enlund M, et al.

    Journal of medical case reports 2018; (12(1)):274 doi:10.1186/s13256-018-1794-9.

    PMID: 30243302
  8. 8

    Urea cycle defects in adulthood: clinical presentation, diagnosis and treatment in genetically encoded hepatic metabolic disorders with a potential for encephalopathy.

    Das AM

    Metabolic brain disease 2025; (40(5)):192 doi:10.1007/s11011-025-01619-5.

    PMID: 40285952
  9. 9

    Decreased plasma l-arginine levels in organic acidurias (MMA and PA) and decreased plasma branched-chain amino acid levels in urea cycle disorders as a potential cause of growth retardation: Options for treatment.

    Molema F, Gleich F, Burgard P, et al.

    Molecular genetics and metabolism 2019; (126(4)):397-405 doi:10.1016/j.ymgme.2019.02.003.

    PMID: 30827756
  10. 10

    Evaluation of dietary treatment and amino acid supplementation in organic acidurias and urea-cycle disorders: On the basis of information from a European multicenter registry.

    Molema F, Gleich F, Burgard P, et al.

    Journal of inherited metabolic disease 2019; (42(6)):1162-1175 doi:10.1002/jimd.12066.

    PMID: 30734935
  11. 11

    Liver transplantation can prevent the progression of neurological damage in hyperornithinemia-hyperammonemia-homocitrullinuria syndrome and maintain long-term metabolic stability - The largest single-center experience.

    Ju H, Wang J, Wang X, et al.

    Orphanet journal of rare diseases 2025; (20(1)):532 doi:10.1186/s13023-025-04077-5.

    PMID: 41126296
  12. 12

    Severe Neurological Sequelae and Radiological Findings in a Lost-to-Follow-Up Case of Hyperornithinemia-Hyperammonemia-Homocitrullinuria Syndrome.

    Mohamed AS, Gupta A, Zakzouk RS

    Cureus 2025; (17(10)):e93690 doi:10.7759/cureus.93690.

    PMID: 41189871

This HHH syndrome page is for informational purposes only and does not constitute medical advice. A metabolic team should guide emergency plans, diet, supplements, and medications for your specific situation.